Table 3.
Time Since Measles (months)b | Fever | Cough | Diarrhea |
---|---|---|---|
OR and 95% CIa | OR and 95% CI | OR and 95% CI | |
Model 1 (2–57 months) | |||
2–12 (n = 62) | 2.08 (0.96–4.51) | 1.53 (0.70–3.33) | 1.02 (0.50–2.11) |
13–24 (n = 54) | 2.14 (1.12–4.08) | 0.94 (0.41–2.17) | 1.44 (0.75–2.78) |
25–57 (n = 60) | 1.54 (0.82–2.87) | 1.37 (0.76–2.46) | 1.58 (0.74–3.37) |
Model 2 (2–36 months) | |||
2–9 (n = 54) | 1.79 (0.80–3.99) | 1.71 (0.74–3.97) | 1.14 (0.50–2.63) |
10–18 (n = 46) | 1.93 (1.03–3.62) | 1.02 (0.50–2.10) | 1.36 (0.68–2.71) |
19–27 (n = 24) | 3.01 (1.18–7.67) | 1.54 (0.63–3.75) | 1.08 (0.35–3.32) |
28–36 (n = 30) | 1.94 (0.80–4.71) | 1.59 (0.68–3.73) | 2.58 (0.93–7.13) |
aControlling for the following additional covariates: measles vaccination (vx), wealth index (WI), vx*WI interaction, breastfeeding, maternal education, parity, age, sex, malaria positive status, rural versus urban residence, residence*WI interaction, (old) province, vx*province interaction, and chronic malnutrition (according to NCHS/CDC/WHO international references standard for height/age SD).
bReference = No history of measles (n=2,157).